Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
The renin-angiotensin and cardiac natriuretic systems play an important role in the pathophysiology of congestive heart failure (CHF). The status of the membrane-bound pulmonary and renal activities of three ectoenzymes involved in the regulation of these systems-angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP), and aminopeptidase A (APA)-was investigated in Wistar rats 3 months after induction of myocardial infarction (MI) and in sham-operated (control) rats. Plasma renin activity and ACE activity, plasma angiotensin II (Ang II) levels, and atrial natriuretic factor levels were simultaneously determined. The lung ACE activity was decreased in MI rats compared with control rats (P < .0001), and this decrease depended on the severity of the heart failure. In contrast, plasma ACE activity was increased in MI rats (P < .01), and this increase was also proportional to the severity of MI. Northern blot analysis showed that the lung ACE mRNA level in severe MI rats was half that of the control rats. Renal ACE activity of the MI rats was not affected, and neither renal or pulmonary NEP nor pulmonary APA activities were altered. Thus, lung ACE gene expression appears to be both organ- and enzyme-specifically regulated during CHF. Whereas plasma renin was increased in heart failure rats, plasma Ang II levels were not different from those of control rats. Thus, decreased lung ACE activity could possibly contribute to keeping plasma Ang II levels in the normal range. The decrease in lung ACE activity and mRNA levels, combined with increased plasma ACE activity, represents a novel aspect of endothelial dysfunction in CHF.(ABSTRACT TRUNCATED AT 250 WORDS)
Huang
H
H
Institut National de la Santé et de la Recherche Médicale, Paris, France.
Arnal
J F
JF
Llorens-Cortes
C
C
Challah
M
M
Alhenc-Gelas
F
F
Corvol
P
P
Michel
J B
JB
D000704:Analysis of Variance; D000804:Angiotensin II / Q000097:blood; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood; D002462:Cell Membrane / Q000201:enzymology; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000503:physiopathology*; D015870:Gene Expression; D006321:Heart / Q000503:physiopathology; D006333:Heart Failure / Q000097:blood / Q000201:enzymology* / Q000503:physiopathology; D007668:Kidney / Q000201:enzymology; D008168:Lung / Q000201:enzymology*; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000201:enzymology* / Q000503:physiopathology; D009929:Organ Size; D007703:Peptidyl-Dipeptidase A / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D010996:Pleural Effusion; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012083:Renin / Q000097:blood
D012333:RNA, Messenger; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D007703:Peptidyl-Dipeptidase A; D012083:Renin